Search Site

Denise E. Chou, MD

  • Assistant Professor of Neurology
  • Director, Columbia University Headache Center
Denise E. Chou, MD

Denise Chou, M.D., obtained her undergraduate degree from Harvard College and her medical degree from Cornell University. She subsequently completed her internship in internal medicine and neurology residency at New York-Presbyterian Hospital/Weill-Cornell campus, followed by a fellowship in headache medicine at the University of California at San Francisco. In addition to outpatient management of headache, she has expertise in procedural therapies, including occipital nerve blocks and Botox injections for chronic headache. She will also be developing an inpatient headache program for refractory headaches using intravenous medication protocols, including an effective detoxification protocol for medication overuse headache. Dr. Chou is committed to delivering the highest level of specialized care to her patients by promoting patient education and creating a tiered headache treatment plan that targets abortive, preventive, and rescue strategies for each individual.

Departmental Appointments

  • Department of Neurology
    Division of Multispecialty Neurology

Education & Training

  • Weill Cornell Medical College
  • Internship: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Residency: NewYork-Presbyterian Hospital/Weill Cornell Medical Center
  • Fellowship: University of California San Francisco Medical Center

Centers/Institutes/Programs

  • Headache and Facial Pain Center

Contact Info

  • Office Phone: 212-305-6876
  • Fax: 212-305-4268

Past Positions

  • Clinical Instructor of Neurology, UCSF Medical Center

Presentations

Research Presentations:

  • Chou DE and Goadsby PJ. Use of Oral Aprepitant for the Management of Nausea with Inpatient Intravenous Dihydroergotamine (DHE) Use. American Academy of Neurology; San Diego, CA, 2013. (platform presentation)
  • Chou DE, Corroo J, Goadsby PJ. Ending emesis: use of aprepitant to manage nausea associated with intravenous dihydroergotamine (DHE). 2013 International Headache Congress; Boston, MA, 2013. (poster presentation)
  • Schankin C, Maniyar F, Hoffmann J, Chou D, Goadsby P. Visual snow: a new disease entity distinct from migraine aura.  American Academy of Neurology; New Orleans, LA, 2012. (poster presentation)
  • Buckle C, Chou DE, Ogedegbe A. Relationship between the clinical and radiographic features of progressive multifocal leukoencephalopathy (PML): correlation with the apparent diffusion coefficient (ADC). The 24th International Congress of Radiology; Cape Town, South Africa, 2006 (poster presentation).
  • Cai H, Chou DE, Rothe H, Porush JG. Regional expression of inducible nitric oxide synthase in the kidney stimulated by lipopolysaccharide. American Society of Nephrology; Philadelphia, PA, 1998 (poster presentation).

Committees/Societies/Memberships

  • American Academy of Neurology
  • American Headache Society
  • International Headache Society

NIH Grants

  • A MULTICENTER, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EXPLORE THE LONG-TERM SAFETY OF TEV-48125 FOR THE PREVENTION OF CLUSTER HEADACHE (P&S Industry Clinical Trial)

    May 1 2017 - May 30 2022

    A PARALLEL GROUP, DOUBLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ALD403 ADMINISTERED INTRAVENOUSLY IN PATIENTS WITH CHRONIC MIGRAINE (P&S Industry Clinical Trial)

    Apr 19 2017 - Apr 19 2022

    A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PLACEBO-CONTROLLED,PARALLEL-GROUP STUDY COMPARING THE EFFICACY AND SAFETY OF 2 DOSE REGIMENS (INTRAVENOUS/SUBCUTANEOUS AND SUBCUTANEOUS) OF TEV-48125 VERSUS PLACEBO FOR THE PREVENTION OF EPISODIC (P&S Industry Clinical Trial)

    Apr 6 2017 - Apr 6 2022

    OPEN-TRIAL ON THE ACUTE TREATMENT OF MIGRAINE USING THE CEFALY DEVICE (P&S Industry Clinical Trial)

    Apr 2 2015 - Apr 2 2020